Viewing Study NCT06863259


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2025-12-24 @ 3:01 PM
Study NCT ID: NCT06863259
Status: RECRUITING
Last Update Posted: 2025-06-13
First Post: 2025-03-03
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
Sponsor: Children's Hospital Medical Center, Cincinnati
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module